C-peptide: The missing link in diabetic nephropathy?

Review of Diabetic Studies

Volumn 6, Issue 3, 2009, Pages 203-210

  Nordquist, Lina ^a   Wahren, John ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

C peptide; Capillary pressure; Diabetes; Glomerular hypertrophy; Microalbuminuria; Nephropathy

Indexed keywords

ALBUMIN; C PEPTIDE; INSULIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTERY TONE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DRUG MECHANISM; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE FUNCTION; MICROALBUMINURIA; NONHUMAN; RENAL PROTECTION; REVIEW; SUBSTITUTION THERAPY; TISSUE OXYGENATION; URINARY EXCRETION;

EID: 76149112593     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.203     Document Type: Review

References (53)

1. O'Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Seminars in nephrology 1997. 17:93-100.
2. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998. 339:69-75.
3. Fiorina P, Folli F, Zerbini G, Maffi P, Gremizzi C, Di Carlo V, Socci C, Bertuzzi F, Kashgarian M, Secchi A. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 2003. 14:2150-2158.
4. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med 2000. 17:181-189.
5. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993. 77:976-981.
6. Nordquist L, Brown RD, Fasching A, Persson P, Palm F. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol 2009. In press.
7. Nordquist L, Moe E, Sjoquist M. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2007. 23:400-405.
8. Samnegard B. Renal effects of C-peptide in experimental type-1 diabetes mellitus. In: Danderyd Hospital and Department of Surgical Sciences. Stockholm: Karolinska Institute, 2005.
9. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001. 60:1258-1265.
10. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986. 46(3):201-206.
11. Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes care 1993. 16:483-492.
12. Persson AE, Gushwa LC, Blantz RC. Feedback pressure-flow responses in normal and angiotensin-prostaglandin-blocked rats. Am J Physiol 1984. 247:F925-F931.
13. Ren YL, Garvin JL, Ito S, Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 2001. 60:1676-1683.
14. Karlsen FM, Holstein-Rathlou NH, Leyssac PP. A re-evaluation of the determinants of glomerular filtration rate. Acta Physiol Scand 1995. 155(4):335-350.
15. Brenner BM, Troy JL. Postglomerular vascular protein concentration: evidence for a causal role in governing fluid reabsorption and glomerulotublar balance by the renal proximal tubule. J Clin Invest 1971. 50:336-349.
16. Leyssac PP. Dependence of glomerular filtration rate on proximal tubular reabsorption of salt. Acta Physiol Scand 1963. 58:236-242.
17. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2001. 107:217-224.
18. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994. 43:629-633.
19. Scherzer P, Nachliel I, Bar-On H, Popovtzer MM, Ziv E. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent. J Endocrinol 2000. 167:347-354.
20. Ikenaga H, Bast JP, Fallet RW, Carmines PK. Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus. J Am Soc Nephrol 2000. 11:1199-1207.
21. Aurell M. Aspects of the role of intraglomerular pressure as a cause of progressive renal damage. Drugs 1988. 35(Suppl 5):42-47.
22. Inman SR, Stowe NT, Nally JV Jr, Brouhard BH, Vidt DG. Dietary protein does not alter intrinsic reactivity of renal microcirculation to angiotensin II in rodents. Am J Physiol 1995. 268:F302-F308.
23. Myers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 1975. 37:101-110.
24. Nordquist L, Lai EY, Sjoquist M, Patzak A, Persson AE. Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. Am J Physiol 2008. 294:R836-R841.
25. Huang DY, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn Schmiedebergs Arch Pharmacol 2002. 365(1):67-73.
26. Samnegard B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjoquist M. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004. 19:1385-1391.
27. Feng MG, Navar LG. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles. Am J Physiol Renal Physiol 2006. 290:F873-F879.
28. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007. 100(3):342-353.
29. Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol 1995. 269:F876-F883.
30. Faulhaber-Walter R, Chen L, Oppermann M, Kim SM, Huang Y, Hiramatsu N, Mizel D, Kajiyama H, Zerfas P, Briggs JP, Kopp JB, Schnermann J. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 2008. 19:722-730.
31. Sallstrom J, Carlsson PO, Fredholm BB, Larsson E, Persson AE, Palm F. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 2007. 190(3):253-259.
32. Ku DD, Sellers BM, Meezan E. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats. Endocrinology 1986. 119:672-679.
33. Wald H, Scherzer P, Rasch R, Popovtzer MM. Renal tubular Na(+)-K(+)-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol 1993. 265:E96-E101.
34. Nordquist L, Stridh S. Effects of proinsulin C-peptide on oxygen transport, uptake and utilization in insulinopenic diabetic subjects - a review. Adv Exp Med Biol 2009. 645:193-198.
35. Ohtomo Y, Aperia A, Sahlgren B, Johansson BL, Wahren J. C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y. Diabetologia 1996. 39:199-205.
36. Zhong Z, Kotova O, Davidescu A, Ehren I, Ekberg K, Jornvall H, Wahren J, Chibalin AV. C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci 2004. 61:2782-2790.
37. Ohtomo Y, Bergman T, Johansson BL, Jornvall H, Wahren J. Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 1998. 41:287-291.
38. Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 2008. 24:331-338.
39. Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T, Saito M. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 2003. 46:1698-1705.
40. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999. 10:2569-2576.
41. Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium han dling without changes in volume expansion. Eur J Clin Invest 2005. 35:330-336.
42. Thaysen JH, Lassen NA, Munck O. Sodium transport and oxygen consumption in the mammalian kidney. Nature 1961. 190:919-921.
43. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003. 46:1153-1160.
44. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 2004. 47:1223-1231.
45. Kunt T, Schneider S, Pfutzner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia 1999. 42:465-471.
46. Osterby R. Lessons from kidney biopsies. Diabetes Metab Res Rev 1996. 12:151-174.
47. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjoquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005. 20:532-538.
48. August P, Suthanthiran M. Transforming growth factor beta signaling, vascular remodeling, and hypertension. New Engl J Med 2006. 354:2721-2723.
49. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y. Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev 2006. 22:313-322.
50. Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am J Physiol 2009. 296:F614-F621.
51. Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 1991. 40:1007-1012.
52. Al-Rasheed NM, Willars GB, Brunskill NJ. C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soc Nephrol 2006. 17:986-995.
53. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992. 35:121-128.